Declan Doogan insider trades
Open-market stock purchases and sales by Declan Doogan, Director at Tenax Therapeutics, Inc, from SEC Form 4 filings since Jan 10, 2018.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 9, 2026 | TENX Tenax Therapeutics, Inc | Bought (not open market) | — |